Search Results 41-50 of 15956 for GLP-1 agonist
Also approved by the FDA is a class of drugs known as glucagonlike peptide 1 agonists, also called GLP-1 agonists. Some of these medicines are approved ...
Angioedema (swelling of the face, lips, tongue, throat, arms, or legs) caused by GLP-1 receptor agonists, history of—Use with caution. ... It is not safe for one ...
... GLP-1 receptor agonist medications. "Once you have the procedure, you've had it, and no one is going to take that away from you or change your insurance ...
Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Heart Disease: Effect, Safety, and Outcomes. JACC Adv. 2025 Apr; 4(4):101674. Epub 2025 Mar 24 ...
Glucagon-Like Peptide-1 Receptor Agonist Therapy Associated With Fewer Diagnoses of Carpal Tunnel Syndrome Within 2 Years of Treatment. Hand (N Y). 2025 Sep ...
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. Anesth Analg. 2026 Apr 1; 142 ...
... agonist pioglitazone, with or without weight loss ... GLP-1 is less marked. In this study the ... Given that gastrointestinal transit is typically delayed by ...
GLP-1 receptor agonists as pharmacological treatment for obesity after spinal cord injury: clinical considerations. Arch Phys Med Rehabil. 2026 Mar 11 [Epub ...
GLP-1 receptor agonists are medicines taken by shot, called injection. They slow digestion and help lower blood sugar levels. Their use is often linked with ...
... GLUCAGON-LIKE PEPTIDE-1 AGONISTS. Clin Gastroenterol Hepatol. 2026 Mar 11 [Epub ahead of print] View PubMed; Lunsford TN, Frazier R, Harris LA. How I ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.